Mirae Asset Global ETFs Holdings
LFCR icon

Mirae Asset Global ETFs Holdings’s Lifecore Biomedical LFCR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.4K Sell
13,024
-476
-4% -$2.4K ﹤0.01% 2969
2026
Q1 		$50.2K Buy
13,500
+306
+2% +$2.11K ﹤0.01% 2903
2025
Q4 		$108K Buy
13,194
+654
+5% +$4.84K ﹤0.01% 2641
2025
Q3 		$92.3K Sell
12,540
-2,561
-17% -$19.4K ﹤0.01% 2699
2025
Q2 		$123K Buy
15,101
+316
+2% +$2.13K ﹤0.01% 2505
2025
Q1 		$104K Buy
14,785
+1,886
+15% +$11.7K ﹤0.01% 2611
2024
Q4 		$95.8K Buy
12,899
+1,209
+10% +$7.72K ﹤0.01% 2714
2024
Q3 		$57.6K Buy
+11,690
New +$61.1K ﹤0.01% 2894

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's LFCR Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Lifecore Biomedical (LFCR) stake by 3.5% in Q2 2026, selling an estimated $2.4K and leaving 13,024 shares worth $68.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2969.

Mirae Asset Global ETFs Holdings first reported a position in LFCR in Q3 2024 and has held it in 8 quarters since. The position peaked at $123K in Q2 2025. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 13,024 shares of Lifecore Biomedical worth $68.4K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 476 Lifecore Biomedical shares in Q2 2026, an estimated $2.4K.
  • Lifecore Biomedical made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2969 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Lifecore Biomedical in Q3 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Lifecore Biomedical position peaked at $123K in Q2 2025.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.